Update on drugs in renal failure.
Bennett
W M
WM
D000700:Analgesics / Q000627:therapeutic use; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001769:Blood; D002301:Cardiac Glycosides / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D006464:Hemoperfusion; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000188:drug therapy*; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects; D010538:Peritonitis / Q000188:drug therapy; D011619:Psychotropic Drugs / Q000627:therapeutic use; D014462:Ultrafiltration
D000700:Analgesics; D000889:Anti-Arrhythmia Agents; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D000897:Anti-Ulcer Agents; D000959:Antihypertensive Agents; D000970:Antineoplastic Agents; D002301:Cardiac Glycosides; D004232:Diuretics; D006993:Hypnotics and Sedatives; D007166:Immunosuppressive Agents; D009125:Muscle Relaxants, Central; D011619:Psychotropic Drugs